SEC Form 4 · accession 0001003642-16-000040
Impax Laboratories, LLC · IPXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Nornhold
Officer — SVP, Technical Operations
Period of report
Oct 25, 2016
Accepted (ET)
Oct 27, 2016 · 12:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001003642
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 25, 2016 | F | 1,829 | $21.80 | D | 78,147 | D | |
| Common StockF1 | Oct 26, 2016 | F | 1,694 | $21.35 | D | 76,453 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Nornhold's payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.